Management of Peptic Ulcer Disease in Patients Taking Antithrombotic Agents [PDF]
The Korean Journal of Helicobacter and Upper Gastrointestinal ResearchThe management of peptic ulcer disease (PUD) in patients receiving antithrombotic therapy requires balancing bleeding and thrombotic risk. The shift from Helicobacter pylori-dominant to drug-induced PUD combined with increasing antithrombotic use has ...
Chang Seok Bang, Eun Jeong Gong
doaj +1 more source
Vitamins in the complex treatment of patients with gastrointestinal diseases
Gastroenterologìa, 2017 The article presents current data on the complex treatment of gastrointestinal diseases with B vitamins as they play an important biological role, not only as a restorative factor, but also as therapeutic agents with diverse pharmacodynamic effect ...
L.M. Shendrik +3 more
doaj +1 more source
Propofol target-controlled infusion for gastrointestinal endoscopy
International Journal of Gastrointestinal InterventionGastrointestinal endoscopy, which includes procedures such as esophagogastroduodenoscopy, colonoscopy, endoscopic ultrasound, and endoscopic retrograde cholangiopancreatography, has become an increasingly routine part of cancer preventive care for the ...
Maharani Pradnya Paramitha +2 more
doaj +1 more source
Reduced risk of gastrointestinal bleeding associated with eupatilin in aspirin plus acid suppressant users: nationwide population-based study [PDF]
The Korean Journal of Internal MedicineBackground/Aims Mucoprotective agents, such as eupatilin, are often prescribed to prevent gastrointestinal (GI) bleeding in addition to an acid suppressant despite the absence of a large-scale study. We evaluated the additional effect of eupatilin on the
Hyun Seok Lee +4 more
doaj +1 more source
High Dose Oestrogen in Life Threatening Obscure Gastrointestinal Bleeding
Acta Medica Indonesiana, 2022 Obscure gastrointestinal bleeding is defined as recurrent or persistent gastrointestinal bleeding in the setting of normal upper and lower endoscopies.
Meng Kang Tee +5 more
doaj +2 more sources
Frontiers in PharmacologyIntroductionLiver fibrosis is a pathological condition in response to chronic liver injuries. Currently, there is no Food and Drug Administration (FDA) approved pharmacotherapy for liver fibrosis.
Yuwei Liu +7 more
doaj +1 more source
A Case of Gastric Mucormycosis Induced Necrotic Gastric Ulcer in Patients with Diabetic Ketoacidosis
The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2016 Mucormycosis is a rare invasive disease with high mortality rates caused by fungi of the zygomycetes class and Mucorales order. Mucormycosis is manifested by a variety of clinical presentations according to the involved site and occurs in ...
Jun Ho Kim +7 more
doaj +1 more source
The Epidemiology of Nonsteroidal Anti-Inflammatory Drugs
Canadian Journal of Gastroenterology, 1999 Nonsteroidal anti-inflammatory drug (NSAID) use has increased dramatically in the past two decades. A large proportion of the elderly population (more than 65 years of age) holds a current or recent NSAID prescription, accounting for approximately 90% of
Jerry Tenenbaum
doaj +1 more source
Diagnostic and Therapeutic Advances of RNAs in Precision Medicine of Gastrointestinal Tumors
BiomedicinesGastrointestinal tumors present a significant challenge for precision medicine due to their complexity, necessitating the development of more specific diagnostic tools and therapeutic agents.
Runhan Liu +6 more
doaj +1 more source
Significant Association of Streptococcus bovis with Malignant Gastrointestinal Diseases
International Journal of Microbiology, 2011 Streptococcus bovis is a Gram-positive bacterium causing serious human infections, including endocarditis and bacteremia, and is usually associated with underlying disease.
Salah Shanan +3 more
doaj +1 more source